---
title: Patient- and care-related benefits of amyloid PET imaging (ENABLE)
euct_id: 2023-503705-10-00
status: Recruiting
sponsor: Deutsches Zentrum Fuer Neurodegenerative Erkrankungen e.V.
canonical_url: "https://parkinsonspathways.com/trials/eu/2023-503705-10-00"
eu_clinical_trials_register: "https://euclinicaltrials.eu/ctis-public/view/2023-503705-10-00"
ctis_last_updated: "2025-04-30T03:41:38.284099611"
source: EU Clinical Trials Information System (CTIS)
---
# Patient- and care-related benefits of amyloid PET imaging (ENABLE)

**EU CT Number:** [2023-503705-10-00](https://euclinicaltrials.eu/ctis-public/view/2023-503705-10-00)

## Key Facts

- **Status:** Recruiting
- **Sponsor:** Deutsches Zentrum Fuer Neurodegenerative Erkrankungen e.V.
- **Start Date:** 2024-09-09
- **Completion Date:** 2028-03-31
- **Conditions:** Dementia in Pick disease, Other vascular dementia, Multi-infarct dementia, Dementia in Alzheimer disease, unspecified, Unspecified dementia, Dementia in Parkinson disease, Dementia in Alzheimer disease with late onset, Mixed cortical and subcortical vascular dementia, Dementia in human immunodeficiency virus [HIV] disease, Dementia in other specified diseases classified elsewhere, Dementia in Creutzfeldt-Jakob disease, Vascular dementia of acute onset, Subcortical vascular dementia, Dementia in Huntington disease, Dementia in Alzheimer disease, atypical or mixed type, Dementia in Alzheimer disease with early onset, Vascular dementia, unspecified, Dementia NOS, Dementia in conditions classified elsewhere, Vascular dementia, Dementia of the Alzheimer's type NOS, Early onset familial Alzheimer's disease, Mixed dementia, Senile dementia
- **Interventions:** Neuraceq 300 MBq/mL solution for injection, VIZAMYL 400 MBq/mL solution for injection

## Member States

Trial is authorized in 1 member state: Germany.

## Sites (24)

- Universitaetsmedizin Greifswald KöR, Greifswald, Germany
- Klinikum rechts der Isar der TU Muenchen AöR, Munich, Germany
- Klinikum der Universitaet Muenchen AöR, Munich, Germany
- Universitaetsmedizin Goettingen, Goettingen, Germany
- Universitaetsklinikum Mannheim GmbH, Mannheim, Germany
- Universitaetsklinikum Ulm AöR, Ulm, Germany
- Klinikum der Universitaet Muenchen AöR, Munich, Germany
- Universitaetsklinikum Giessen und Marburg GmbH, Marburg, Germany
- Medical Center - University Of Freiburg, Freiburg Im Breisgau, Germany
- Rostock University Medical Center, Rostock, Germany
- University Hospital Cologne AöR, Cologne, Germany
- Universitaetsklinikum Tuebingen AöR, Tuebingen, Germany
- Universitaetsklinikum Essen AöR, Essen, Germany
- Deutsches Zentrum Fuer Neurodegenerative Erkrankungen e.V., Bonn, Germany
- Universitaet Leipzig, Leipzig, Germany
- Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR, Mainz, Germany
- University Of Erlangen Nuremberg, Erlangen, Germany
- Central Institute Of Mental Health, Mannheim, Germany
- Technische Universitat Dresden, Dresden, Germany
- Universitaetsklinikum Magdeburg AöR, Magdeburg, Germany
- Charite Universitaetsmedizin Berlin KöR, Berlin, Germany
- Philipps University Marburg, Marburg, Germany
- University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- Charite Universitaetsmedizin Berlin KöR, Berlin, Germany

## Eligibility (CTIS)

- **Minimum age:** 18 Years
- **Sex:** ALL

```
Condition: Dementia in Pick disease; Other vascular dementia; Multi-infarct dementia; Dementia in Alzheimer disease, unspecified; Unspecified dementia; Dementia in Parkinson disease; Dementia in Alzheimer disease with late onset; Mixed cortical and subcortical vascular dementia; Dementia in human immunodeficiency virus [HIV] disease; Dementia in other specified diseases classified elsewhere; Dementia in Creutzfeldt-Jakob disease; Vascular dementia of acute onset; Subcortical vascular dementia; Dementia in Huntington disease; Dementia in Alzheimer disease, atypical or mixed type; Dementia in Alzheimer disease with early onset; Vascular dementia, unspecified; Dementia NOS; Dementia in conditions classified elsewhere; Vascular dementia; Dementia of the Alzheimer's type NOS; Early onset familial Alzheimer's disease; Mixed dementia; Senile dementia
Age groups: elderly 65+, adults 18-64
Sex: male, female
Includes a vulnerable population.
```

---

*Canonical: https://parkinsonspathways.com/trials/eu/2023-503705-10-00*  
*HTML version: https://parkinsonspathways.com/trials/eu/2023-503705-10-00*  
*Source data: https://euclinicaltrials.eu/ctis-public/view/2023-503705-10-00*